Representative Image
Antiviral drug Remdesivir has shown positive results in the treatment of COVID-19 patients, US-based pharma company Gilead Sciences has said.
In its third phase of clinical trial, a 5-day dosage of the medicine has reportedly improved the condition of 50 per cent of the patients with many discharged from hospitals in two weeks.
“Certainly, it’s a positive, a very positive event,” US President Donald Trump told reporters on Wednesday in response to a question related to the development of Remdesivir.
However, the drug has not been licensed or approved globally for the treatment of COVID-19 patients.
Meanwhile, a study to determine the efficacy of the medicine for a five-day course as compared to a 10-day treatment regime is underway, the company said.
Remdesivir was found to kill viruses like Ebola, Marburg, MERS and SARS. The medication disables virus RNA (ribonucleic acid) replication.
However, the drug failed the human trial stage for treating the Ebola virus in 2018-19.
Bhubaneswar: The Capital Region Urban Transport (CRUT), a public transit agency in Odisha, on Friday…
Mumbai: Over the years, female actresses have often outshone their male confreres at the domestic…
Bhubaneswar: War of words between the ruling Bharatiya Janata Party (BJP) and opposition Biju Janata…
Bhubaneswar: Local boy Kabir Hans delighted the home crowd at the Kalinga Stadium Tennis Centre by…
Mumbai: Television actor Nitin Chauhan’s untimely demise at the age of 35 has once again…
Cuttack: Vendors will not be allowed to do business on footpaths during the upcoming Bali…
Mumbai: Sandeep Pattanaik completed a fighting century but that didn’t help Odisha avoid a follow-on…
Bhubaneswar: After several Biju Janata Dal (BJD) leaders blamed VK Pandian for the regional party’s…